Search results
Apr 1, 2024 · Precision Medicine for Parkinson’s Disease Is Focus of New Yale Center. April 01, 2024. by Isabella Backman. Clemens Scherzer, MD, is on a mission to revolutionize the treatment of Parkinson’s disease through the use of genomics and artificial intelligence (AI) to create tailored therapeutics.
Nov 14, 2016 · Dr. Clemens Scherzer is a Physician-Scientist and the Founding Director of the Center for Advanced Parkinson Research of APDA, Brigham Health and Harvard. He is also the Director of the Precision Neurology Program of Brigham & Women’s Hospital and Professor of Neurology at Harvard Medical School.
Clemens Scherzer, M.D. is a physician-scientist and the Stephen & Denise Adams Professor of Neurology at Yale School of Medicine. He heads the Stephen & Denise Adams Center for Parkinson's Disease Research of Yale School of Medicine, an inter-departmental incubator of precision medicine.
Clemens Scherzer, M.D. is a physician-scientist and the Stephen & Denise Adams Professor of Neurology at Yale School of Medicine. He heads the Stephen & Denise Adams Center for Parkinson’s Disease Research of Yale School of Medicine, an inter-departmental incubator of precision medicine.
- clemens.scherzer@yale.edu
- 100 College Street, Fl 9, Ste C947, New Haven, 06510, CT
Oct 23, 2023 · The director of the center will be Clemens Scherzer, MD, who comes to Yale in January 2024 from Harvard Medical School, where he is professor of neurology, director of the APDA Center for Advanced Parkinson Research, and director of the Precision Neurology Program at Brigham and Women’s Hospital.
Clemens Scherzer is a physician-scientist and movement disorders specialist. He heads the Neurogenomics Lab of Harvard and Brigham and Women's Hospital and co-founded the Harvard Biomarkers Study of Brigham & Women's Hospital, Massachusetts General Hospital, and the Harvard NeuroDiscovery Center.
People also ask
Who is Dr. Paul Scherer?
Who is Dr. Scherz?
Where is Dr. Schertzer's office located?
Who is Clemens Scherzer?
Nov 7, 2023 · The neurological disorder currently affects an estimated one million people in the United States. The director of the new center will be Clemens Scherzer, MD, who comes to Yale in January 2024 from Harvard Medical School.
